Stacey McKenna, Resident Senior Fellow, Integrated Harm Reduction, R Street Institute In SUPPORT of Senate Bill 421, “Pharmacist; remote verification and counseling in opioid treatment programs.” ...

New national commission brings together leading experts to improve access to high-quality, patient-centered, evidence-based ...

Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its fourth quarter and full-year 2025 financial results on Thursday, February 26, 2026, at 7:00 a.m. U.S. EST.

“This transition marks an important next chapter for the company. With Rick joining as Bicycle Health’s CEO, the company is doubling down on its commitment to expanding access to life-saving OUD care ...

Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates.

Those who experience the paralyzing psychological and social effects of obsessive-compulsive disorder can often find relief ...

IPI is subject to the reporting requirements of the U.S. Securities and Exchange Commission (“SEC”) as a domestic issuer and applicable exchange rules of Nasdaq. Further details regarding the ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain.

Click Therapeutics is well on its way to doing both – and in a sit down interview at the Informa Biotech Showcase in San ...

Virginia university leads trial testing ARD-201, an oral drug to maintain weight loss after stopping GLP-1 treatments like ...

In a study published in the journal Iraq, Dr. Troels Arbøll analyzed medical prescriptions from ancient Mesopotamia to ...

Alcohol can interact dangerously with common medications and supplements. Learn which combinations to avoid and how to reduce ...